CLAYMONT, Del.–(BUSINESS WIRE)–#AI–Vital, a leading artificial intelligence- (AI) driven digital health company, announced a significant milestone with the publication of a groundbreaking peer-reviewed scientific publication in the Journal of Medical Internet Research AI (JMIR AI). The paper focuses on sepsis prediction, marking a crucial step in Vital’s ongoing commitment to delivering solutions that drive better patient outcomes while providing a positive patient experience.
Sepsis is a life-threatening condition that must be treated promptly and is often difficult to detect, even by experienced physicians, in its earliest stages. The peer-reviewed paper, “Sepsis Prediction at Emergency Department Triage Using Natural Language Processing: Retrospective Cohort Study,” highlights the power of artificial intelligence (AI) in predicting sepsis at the earliest stages.
“For years, Vital has helped improve patient experience scores, follow-up adherence, and patient understanding,” said Vital’s CEO Aaron Patzer. “And we’re improving outcomes as well. Early inpatient outcomes appear to be shaving 0.5-days off the average inpatient stay, which is non-trivial. Our latest research on sepsis prediction reinforces this track record of patient impact.”
The study reveals that sepsis can accurately be predicted at initial emergency department (ED) presentation, using nursing triage notes and clinical information available within the patient’s medical record at the time of triage. This breakthrough indicates that machine learning (ML) and natural language processing (NLP) can facilitate timely and reliable alerting for intervention, and holds significant potential for saving lives.
Findings include:
To coincide with this publication, Vital is announcing future plans to deliver solutions that use predictive analytics to notify physicians and staff about quality and safety issues. Vital’s chief medical officer and practicing emergency department physician, Dr. Justin Schrager shared, “Vital is currently beta testing our sepsis model within our client community. The results continue to encourage and validate the need for us to double down on predictive analytics, solidifying our position as leaders in AI who are committed to innovation.”
“While I’m proud of Vital’s usage metrics, the Google ratings we’ve helped clients achieve, and hospitals’ ROI, I’m certainly looking forward to one day putting a big meter on the website: number of healthy years created,” Patzer added.
About Vital:
Vital is on a mission to radically improve patient experience with software that gives more control, clarity, and predictability to care. Using advanced artificial intelligence (AI), Vital transforms complex health record data into easy-to-use, personalized interfaces that engage and empower over one million patients per year – no downloads or passwords required. With Vital, patients can better understand progress toward discharge, request service and comfort items, set goals, view labs, share health status with family, book follow-up care, and much more. Over 100 hospitals use Vital to improve patient satisfaction, drive growth and patient loyalty, achieve better clinical outcomes, and reduce workload for care teams.
Founded by Mint.com creator Aaron Patzer (@apatzer) and Emergency Physician Dr. Justin Schrager, Vital is a HIPAA-compliant cloud-based experience layer that integrates with any electronic health record system. For more information, please visit vital.io or follow us on LinkedIn or Twitter.
Contacts
For media inquiries, interviews, or additional information, please contact:
Morgan Watts
Director of Marketing
morgan.watts@vital.io
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…